Pontifax Management 4 G.P. Ltd.

Pontifax Management 4 G.P. (2015) Ltd. is listed in filings as 10% Owner at Keros Therapeutics, Inc.. This profile follows SEC Form 4 activity through Oct 17, 2025, including sale activity. Recent filings connect the profile to Keros Therapeutics, Inc. (KROS). The current snapshot covers public activity from Oct 17, 2025. Reported amounts are shown as $2.8M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.